Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins

Shai Carmi, Ken Hui, Ethan Kochav, Xinmin Liu, James R. Xue, Fillan S. Grady, Saurav Guha, Kinnari Upadhyay, Dan Ben-Avraham, Semanti Mukherjee, B.m. Bowen, Tinu Thomas, Joseph Vijai, Marc Cruts, Guy Froyen, Diether Lambrechts, Stéphane Plaisance, Christine Van Broeckhoven, Philip Van Damme, Herwig Van Marck, Nir Barzilai, Ariel Darvasi, Kenneth Offit, Susan Bressman, Laurie J. Ozelius, Inga Peter, Judy H. Cho, Harry Ostrer, Gil Atzmon, Lorraine N. Clark, Todd Lencz, Itsik Pe’erNature Communications 2014 · DOI

Abstract

The Ashkenazi Jewish (AJ) population represents a unique genetic isolate, offering significant advantages for disease mapping but presenting challenges for standard clinical variant filtering. This study presents a high-depth reference panel of 128 AJ genomes, demonstrating that population-specific resources can drastically reduce clinical "noise" and improve imputation accuracy. Beyond clinical utility, the data provides a high-resolution window into AJ history, confirming a severe medieval bottleneck and a balanced ancestral admixture of European and Middle Eastern lineages.

The Challenge of Genetic Isolates

In clinical genomics, identifying disease-causing mutations requires filtering out common, benign variants. Standard reference panels, such as those from the 1000 Genomes Project, often lack the resolution needed for specific populations. For the AJ population, variants that appear rare in broad European datasets may be common locally, leading to false positives in diagnostic workflows. This study addresses this gap by creating a dedicated, high-depth AJ reference panel.

Methods and Variant Discovery

Researchers performed whole-genome sequencing on 128 AJ individuals at an average depth of >50x. To benchmark the panel's utility, they compared it against a cohort of 26 Flemish (FL) individuals and existing public databases.

Variant discovery and population modeling. Panel (a) shows the total number of variants and the percentage of novel variants in AJ vs FL. Panel (b) details novel variants per AJ genome. Panel (c) models the number of new segregating sites as more individuals are sequenced.

The AJ panel revealed 47% more novel variants per genome than the Flemish panel. This increased sensitivity is crucial for clinical applications: the AJ-specific panel proved eightfold more effective at filtering benign variants from clinical genomes compared to standard European panels. Additionally, the panel improved imputation accuracy—the ability to predict unobserved genotypes—by 28% for standard SNP arrays.

Illuminating Population History

The high-resolution sequence data allowed for a detailed reconstruction of AJ history through Identical-By-Descent (IBD) analysis and Allele Frequency Spectrum (AFS) modeling.

The Medieval Bottleneck

The study confirmed a severe population bottleneck occurring approximately 600–800 years ago. During this period, the effective population size dwindled to just ~350 individuals. This "founder effect" explains the high degree of genetic sharing observed within the modern population.

Distribution of genome sharing (IBD) within and between populations. The AJ population shows significantly higher levels of internal sharing compared to the Flemish population or between the two groups.

As shown in the sharing analysis, IBD segments are 7.9 times more abundant within the AJ population than within the Flemish cohort. This high level of sharing means that even a relatively small panel of 128 individuals can cover a significant portion of any AJ genome.

Ancestral Origins

Modeling of ancient histories revealed that the AJ population is a nearly even admixture (approx. 49%/51%) of European and Middle Eastern lineages. The split between these ancestral source populations was dated to 12–25 thousand years ago, suggesting that the Middle Eastern component likely represents the population that repopulated Europe following the Last Glacial Maximum.

Conclusion and Future Directions

The AJ reference panel is a transformative resource for population-targeted personal genomics. By reducing diagnostic noise and improving imputation, it directly enhances the accuracy of genetic medicine for millions. While the current panel is robust, future work involving larger cohorts and ancient DNA will continue to refine our understanding of the complex migratory and evolutionary history of the Ashkenazi Jewish population.

Summary updated

Abstract

The Ashkenazi Jewish (AJ) population is a genetic isolate close to European and Middle Eastern groups, with genetic diversity patterns conducive to disease mapping. Here we report high-depth sequencing of 128 complete genomes of AJ controls. Compared with European samples, our AJ panel has 47% more novel variants per genome and is eightfold more effective at filtering benign variants out of AJ clinical genomes. Our panel improves imputation accuracy for AJ SNP arrays by 28%, and covers at least one haplotype in ≈ 67% of any AJ genome with long, identical-by-descent segments. Reconstruction of recent AJ history from such segments confirms a recent bottleneck of merely ≈ 350 individuals. Modelling of ancient histories for AJ and European populations using their joint allele frequency spectrum determines AJ to be an even admixture of European and likely Middle Eastern origins. We date the split between the two ancestral populations to ≈ 12-25 Kyr, suggesting a predominantly Near Eastern source for the repopulation of Europe after the Last Glacial Maximum.
BibTeX
@inproceedings{carmi2014sequencing,
  author = {Shai Carmi and Ken Hui and Ethan Kochav and Xinmin Liu and James R. Xue and Fillan S. Grady and Saurav Guha and Kinnari Upadhyay and Dan Ben-Avraham and Semanti Mukherjee and B.M. Bowen and Tinu Thomas and Joseph Vijai and Marc Cruts and Guy Froyen and Diether Lambrechts and Stéphane Plaisance and Christine Van Broeckhoven and Philip Van Damme and Herwig Van Marck and Nir Barzilai and Ariel Darvasi and Kenneth Offit and Susan Bressman and Laurie J. Ozelius and Inga Peter and Judy H. Cho and Harry Ostrer and Gil Atzmon and Lorraine N. Clark and Todd Lencz and Itsik Pe’er},
  title = {{Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins}},
  booktitle = {Nature Communications},
  year = {2014},
  doi = {10.1038/ncomms5835},
}
Figure